e-prescribing market

E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 20192026

  • Published Date: 2020-10-07
  • Report ID: 571
  • Pages: 190
  • Format: prudent report format

Electronic prescribing or e-prescribing is a digital application that securely provides bidirectional electronic information exchange between payers/PBMs, pharmacies, prescribing providers, directly or through an intermediary network. E-prescribing includes routing prescriptions that ensures prescribed drug against the patients health formulary of covered drugs, obtains prior authorization, gains any known patient drug allergies, identifiesany drug-drug interactions, provides access to patients medication history from external sources, and sends or receives acknowledgement of prescriptions filled. The major capability of e-prescribing is to support important process in care delivery, such as medication management, medication reconciliation, and prior authorization, this in turn is driving the e-prescribing market growth.
Factors that drive the growth of the global e-prescribing market include rise in focus of developed government initiatives and incentive programs toward adoption of e-prescribing solutions, rise in focus on the reduction of fraud and abuse of controlled substances, and increase in need to curtail escalating healthcare costs. However, e-prescribing solutions are costly to integrate in the EHR or HIT systems and rise in concerns associated with security & workflow of digital healthcare records are major factors that hinder the e-prescribing market growth. Furthermore, increase in development of healthcare infrastructure and rise in adoption of e-prescribing in the developing countries across Asia-Pacific are opportunistic factors of the global e-prescribing market.
The e-prescribingmarketis segmented on the basis of component,deployment,end user, and region. Bycomponent, it is categorized into solutionsand services.On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classifiedinto hospitals, office-based physicians, and pharmaceuticals.By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the e-prescribing marketinclude Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the current & future trends of the market to elucidate the imminent investment pockets.
Information about key drivers, restraints, and opportunities and their impact analysis on the global e-prescribing market size is provided.
Porters five forces analysis illustrates the potency of the buyers and suppliers operating in the global e-prescribing industry.
The quantitative analysis of the market from 2018 to 2026 is provided to determine the global e-prescribing market potential.
KEY MARKET SEGMENTS
By Component
Solutions
Services

By Deployment
On-premise
Cloud

By End User
Hospitals
Office-based Physicians
Pharmaceuticals

By Region
North America
o U.S.
o Canada
Europe
o Germany
o France
o UK
o Rest of Europe
Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
LAMEA
o Latin America
o Middle East
o Africa

KEY MARKET PLAYERS
Allscripts Healthcare, LLC
Athenahealth, Inc.
Cerner Corporation
Change Healthcare
DrFirst.com, Inc.
eClinicalWorks
Epic Systems Corporation
Medical Information Technology, Inc.
Practice Fusion, Inc.
Surescripts


CHAPTER 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO PERSPECTIVE
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs
3.4.2. Restraints
3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues
3.4.3. Opportunities
3.4.3.1. Growth in the developing countries across Asia-Pacific
3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET
CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT
4.1. OVERVIEW
4.2. SOLUTIONS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. SERVICES
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT
5.1. OVERVIEW
5.2. WEB & CLOUD-BASED
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. ON-PREMISE
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
CHAPTER 6: E-PRESCRIBING MARKET, BY END USER
6.1. OVERVIEW
6.2. HOSPITALS
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. OFFICE-BASED PHYSICIANS
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. PHARMACEUTICALS
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: E-PRESCRIBING MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast, by region
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment
7.3.5.1.3. Market size and forecast, by end user
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user
7.3.5.4. Rest of Europe
7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user
7.4.5.4. Rest of Asia-Pacific
7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country
7.5.5.1. Latin America
7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user
7.5.5.2. Middle East
7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user
7.5.5.3. Africa
7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS
8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration
8.4. PATENT ANALYSIS
8.4.1. By region (2016-2019)
8.4.2. By applicant
CHAPTER 9: COMPANY PROFILE
9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ATHENAHEALTH, INC.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. CERNER CORPORATION
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. CHANGE HEALTHCARE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DRFIRST
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments
9.6. ECLINICALWORKS
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. EPIC SYSTEMS CORPORATION
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDICAL INFORMATION TECHNOLOGY, INC.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments
9.9. PRACTICE FUSION, INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. SURESCRIPTS
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments

CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.